What is OABI (OABI) stock price today?

OABI (OABI) is currently trading at $2.00, up 2.04% today.

What is OABI P/E ratio?

OABI's P/E ratio is -3.84. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is OABI return on equity (ROE)?

OABI's return on equity (ROE) is -24.34%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is OABI's market cap?

OABI has a market capitalization of $238.18M.

NASDAQ · Biotechnology

OABI (OABI) Stock

$2.00 +2.04% NASDAQ: OABI Healthcare

Valuation

Metric	Value
Price	$2.00
Market Cap	$238.18M
P/E Ratio	-3.84
P/B Ratio	0.98
P/S Ratio	8.98
EPS (TTM)	$-0.57
52-Week High	$2.79
52-Week Low	$1.30
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-24.34%
ROA	-21.59%
ROCE	-26.97%
Gross Margin	-373.68%
Operating Margin	-378.95%
Net Margin	-1.88%
Debt/Equity	0.07
Current Ratio	4.06

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$35.0M	$59.0M	$34.0M	$26.0M	$19.0M
Operating Profit	$-36.0M	$-27.0M	$-69.0M	$-75.0M	$-72.0M
Net Profit	$-27.0M	$-22.0M	$-51.0M	$-62.0M	$-65.0M
EPS	$-0.24	$-0.26	$-0.51	$-0.61	$-0.57
Op Margin	-102.5%	-45.1%	-203.2%	-282.3%	-383.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$304.0M	$421.0M	$375.0M	$326.0M	$301.0M
Total Liabilities	$70.0M	$80.0M	$61.0M	$38.0M	$34.0M
Cash	$0	$33.0M	$16.0M	$28.0M	$26.0M
Borrowings	$14.0M	$26.0M	$26.0M	$23.0M	$20.0M

Latest News

OmniAb to Report Second Quarter 2026 Financial Results on August 6 Business Wire · Jul 16, 2026 OmniAb Appoints Amechi Nwachuku as Chief Operating Officer MT Newswires · Jul 13, 2026 OmniAb Names Amechi Nwachuku Chief Operating Officer Business Wire · Jul 13, 2026 The Cancer Therapy Strategy VERAXA Is Betting the Company On Exec Edge · Jul 6, 2026 OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher? Insider Monkey · Jul 3, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-6.0M	$-4.0M	$2.0M	$-40.0M	$-36.0M
Investing Cash Flow	$-8.0M	$-90.0M	$-20.0M	$36.0M	$6.0M
Financing Cash Flow	$10.0M	$14.0M	$-1.0M	$2.0M	$0
Net Cash Flow	$0	$34.0M	$-17.0M	$11.0M	$-2.0M
Free Cash Flow	$-10.0M	$-21.0M	$1.0M	$-42.0M	$-37.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-10.02%
Quick Ratio	4.80
Interest Coverage	—
Return 1Y	-5.12%
Return 3Y	-61.65%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ARMPArmata Pharmaceuticals, Inc.	$4.64	-0.43%	-0.60	$170.34M	0.00%
CCCC	$3.52	-0.85%	-2.54	$389.20M	0.00%
CDXS	$1.47	-2.00%	-5.06	$133.62M	0.00%
IMDXInsight Molecular Diagnostics Inc.	$4.70	-0.84%	-3.13	$151.76M	0.00%
IPHAInnate Pharma S.A.	$1.79	+0.14%	-2.89	$168.32M	0.00%

About OABI

OABI is led by CEO Matthew W. Foehr, employs 114 people, headquartered in US, publicly traded since 2021.

OABI stock trades at $2.00 with a market capitalization of $238.18M. The stock is valued at a price-to-earnings (P/E) ratio of -3.84, price-to-book of 0.98, price-to-sales of 8.98. Over the past 52 weeks the stock has ranged between $1.30 and $2.79, and currently trades 28.3% below its 52-week high.

On profitability, OABI generates a return on equity (ROE) of -24.34%, return on capital employed of -26.97%, an operating margin of -378.95%, a net profit margin of -1.88%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides